MMED Earnings Date: Nov 10, 2026 (Estimated) — MiniMed Group, Inc.

NASDAQ

Updated

Price $18.93
Market Cap $5.2B
P/E -15.3
52W Range $10.65 – $24.43
Next Earnings · After close (est.)

When is MMED's next earnings date?

MiniMed Group, Inc. (MMED) is expected to report Q2 2027 earnings on Tuesday, November 10, 2026 at 5:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $0.13 on revenue of $826.5M.

How did MMED do in its last earnings report?

In its most recent report on Sep 1, 2026 (Q1 2027), MiniMed Group, Inc. posted EPS of $0.00 versus the $0.12 estimate, a miss of 100.0%. Revenue was $843.0M against a $826.8M estimate. The stock's 1-day post-earnings move was +10.7%.

How much does MMED stock move after earnings?

MMED beat EPS estimates in 0 of its last 2 reported quarters. Over the last 2 reports the stock moved an average of 13.3% (up or down) in the day after earnings.

About MiniMed Group, Inc.

MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management. The company's diverse portfolio features essential tools like insulin pumps, continuous glucose monitoring (CGM) systems, infusion sets, specialized software platforms, and various supplementary accessories. These innovations are crafted to enable both patients and healthcare providers to accurately monitor and precisely regulate blood glucose levels. The enterprise was established in 1983 by Alfred E. Mann and is currently headquartered in Northridge, California.

Earnings History

DatePeriodEPS Est.EPS Act.SurpriseRevenueResult1D Δ1W Δ1M Δ
2026-09-01Q1 20270.120.00-100.00%$843.0M❌ Miss+10.66%+15.10%-3.90%
2026-06-03Q4 2026-0.22-0.68-209.09%$837.0M❌ Miss+15.94%+22.93%+26.75%

Showing last 2 quarters.

Revenue by segment & region

By segment

FY2025 · $1.55B total · annual

SegmentShareRevenueYoY
Consumables61.8%$956.0M—
Pumps35.3%$546.0M—
Product and Service, Other3.0%$46.0M—

By region

FY2025 · $3.10B total · annual

SegmentShareRevenueYoY
Non-US70.4%$2.19B—
UNITED STATES29.6%$917.0M—

Source: company filings via FMP. YoY compares the same fiscal period a year earlier.

Learn More

Explore More

Financial data from licensed market-data providers; risk factors from SEC EDGAR filings. AI-powered analysis. Data last updated .